You can’t believe what anyone just types
Where everyone would like to be but will this get noticed.
I know things aren’t going well but at this price they are so cheap to buy, Avani throwing money at it and invested at 18p….DYOR
Another wishy washy RNS
Someone is selling the same buy amounts to make it look like the same person…….its surely not and I’m pretty confident about that:
Surely someone just playing games with you .
MM’s aren’t going to raise this as there’s lots of sellers just selling into the news and not enough buyers.
£20k at 2.89p wont be happy from yesterday
RNS on lse just invites traders, need investors.
DYOR everyone, don’t get caught out by traders with ramping commenting wanting to sell later in the day.
GLA
Hi Sianna
Yes never not been here. Just thought best to sit and wait and put my energy in other stocks. This is a waiting game, fingers crossed still.
Sorry Twib……best to ignore and sit and wait.
Twin will be the trader who bought at 1pm then sold 3 hrs later.
Its a great share to be invested in and never said it wasn't.
just knowing your on the board was a negative.
Tillychatshi T
Get back to Eua and carry on your nonsense ramping there.
Major advantages of our CBRs and BMEs for combatting viral infections include:
(1) the use of a "bait" makes CBRs and BMEs insensitive to mutations of the targeted virus, preventing the development of resistance (unlike antibodies); as long as the virus is infective and uses the same "door" to enter a cell, it will be eliminated by CBR-based treatments. The bait resembles a handle of the door that the virus uses to enter a cell.
(2) CBRs and BMEs are assembled from parts of naturally occurring cellular receptors and/or engagers that are responsible for the function of immune cells and endow the host's own immune system with the ability to destroy invading pathogens.
(3) CBRs and BMEs are modular synthetic receptors and/or immune cell engagers that can be reconfigured rapidly to attack almost any virus. It is important to stress that this new technology also works in cancer, on malignant cells. This work thus strengthens the Company's anti-cancer work, and importantly opens up many opportunities to work with public bodies, such as the military, the National Institutes of Health, the Biomedical Advanced Research and Development Authority ("BARDA"), as well as other leading public health-focused foundations.
Reading…….God help me.
Rums all round and all that nonsense, I was ready this sxxxxe as I was losing £1000’s
Oh no………before I invested here I wish I’d of known tilly was here…..his positive commentary helped me lose a fortune on Eurasia.
I believe lots are moving to Hemo and Bitcoin based shares.